Pregnancy Clinical Trial
Official title:
Effect of Regular Exercise in Prevention of Excessive Weight Gain in Pregnancy. A Single Blind Randomized Controlled Trial
Background:
Use of variable definitions of exercise and disparate results, emphasize the need of proper
randomized controlled trials examining the relationship between physical activity and weight
development during pregnancy. So far, only few intervention studies aiming at weight
management during pregnancy have been performed (Gray-Donald et al., 2000,Olson et al.,
2004,Polley et al., 2002,Kinnunen et al., 2007). Moreover, most of these interventions have
focused on how gestational weight gain may be altered through individual counselling
combining diet and exercise habits, rather than supervised training. Search on PubMed
revealed no randomized controlled trial where the main outcome was to investigate how the
effect of supervised structured exercise may reduce the proportion of women gaining more
weight than optimal. The aim of the present study is to assess whether a 12-week aerobic
exercise program during pregnancy can prevent excessive gestational weight gain.
Method:
This is a single blind randomized controlled trial to evaluate the effects of a structured,
supervised aerobic exercise program on weight gain stabilization in primiparous pregnant
women. The aim is to include 100 women. Interested women eligible for the present study will
be invited to a pre-test including interview and assessments at the university. The women
are examined three times during the study period. The first visit is between 12 and 24 weeks
of gestation, the second at week 36-38 and the last 8-12 week after delivery. The exercise
program consists of supervised exercise for 60 minutes, performed at least 2 times per week,
for 12-16 weeks. Compliance with the training protocol is controlled by the instructors and
registrations in the womens personal training diary
Background:
Data from population-based surveys and longitudinal observational studies generally support
that inactive men and women have higher body weight and BMI than physically active adults
(US Departmentof Health and Human Services, 1996,Williamson et al., 1993,Sherwood et al.,
2000,Anderssen et al., 2007). Studies examining the impact of exercise on maternal weight
gain are varied and limited. Two different meta- analysis's found no difference in maternal
weight gain between exercisers and non-exercisers (Kramer, 2002,Lokey et al., 1991). In a
review from 2004 it is suggested that women who exercise before pregnancy and continue to do
so during pregnancy tend to weigh less and gain less weight that controls (Siega-Riz et al.,
2004). A recent study of Haakstad et al (Haakstad et al., 2007) found that women who
continued to exercise regularly in the 3rd trimester had significantly lower total weight
gain. In addition, women reporting high exercise frequency in the 3rd trimester ( ≥ 4 times
per week), the proportion exceeding IOM's weight gain recommendations was significantly
lower compared to women exercising less frequently (1-3 times per week)(Haakstad et al.,
2007). These results indicate that there may be a dose-respons relationship, with higher
levels of exercising being more effective than moderate and low levels for the prevention of
high maternal weight gain.
So far, only few intervention studies aiming at weight management during pregnancy have been
performed (Gray-Donald et al., 2000,Olson et al., 2004,Polley et al., 2002,Kinnunen et al.,
2007). Moreover, most of these interventions have focused on how gestational weight gain may
be altered through individual counselling combining diet and exercise habits, rather than
supervised training. Search on PubMed revealed no randomized controlled trial where the main
outcome was to investigate how the effect of supervised structured exercise may reduce the
proportion of women gaining more weight than optimal. The aim of the present study is to
assess whether a 12-week aerobic exercise program during pregnancy can prevent excessive
gestational weight gain.
Method:
Participants This is a single blind randomized controlled trial to evaluate the effects of a
structured, supervised aerobic exercise program on weight gain stabilization in primiparous
pregnant women. Participants will be recruited via health practitioners (physicians,
midwifes), articles and advertisement in the newspapers, official websites for pregnant
women, through flyers and word of mouth. The aim is to include 100 women. With power = 0.85
and alfa = 5%, the present study is designed to detect a standardized difference in total
weight gain of 0.6. Assuming that the standard deviation of weight gain is 5 kilos, then the
actual weight gain has to be ∆= 3 kilos.
Inclusion/exclusion At first contact by phone, the aim and implications of the study are
explained and the eligibility criteria are checked. Primiparous women who have not
participated in a structured exercise program, including significant amounts of walking for
the past six months is eligible for the trial. Other inclusion criteria are ability to read,
write and speak Norwegian, and to be within their first 24 weeks of pregnancy. Exclusion
criteria is severe heart disease, pregnancy induced hypertension, history of more than two
miscarriages, persistent bleeding after week 12 of gestation, poorly controlled thyroid
disease, poorly controlled pre-eclampsia and other diseases that could interfere with
participation (Artal and O'Toole, 2003). In addition, all women who live to far from the
university to be able to attend weekly training groups will be ineligible.
Procedure and outcome measures Interested women eligible for the present study will be
invited to a pre-test including interview and assessments at the university. All visits are
accomplished during daytime and at normal working hours. The women are examined three times
during the study period. The first visit is between 12 and 24 weeks of gestation, the second
at week 36-38 and the last 8-12 week after delivery. Each visit lasts about 60-75 minutes.
There is no induction to the exercise program before gestation week 12.
At the first appointment, the principal investigator (LH) completes an initial interview and
health screening with all participants. The requirements of the study are explained and
possible contraindications for exercise are identified again. Data from the Pregnancy Health
Card is registered. The baseline questionnaire covers demographic information (e.g. age,
pregnancy week, smoking habits, education, occupation), assessment of daily life physical
activity and sedentary behaviour (at work, in transportation and household). In addition,
there is registration of pregnancy complications (e.g. pelvic girdle and low back pain,
urinary incontinence, high blood pressure, pre-eclampsia, vomiting, fatigue). The second
questionnaire is self administrated and includes questions about perceived quality of life
and health status the last four weeks. Finally, the women's pre-pregnancy weight is
registered and hight and weight is measured using a digital beam scale. Anthropometric
estimation of maternal body composition is assessed by Holtain caliper, measuring left side
skinfold thickness of the triceps, abdomen and thigh. Each measurement is done twice and
held for 5-10 seconds. A mean value of the two is computed. If the two skinfold assessments
differ more than 2mm, the skinfold is measured a third time and the mean of the three values
are calculated.
The same assessments described above are obtained at the second visit (week 36-38 of
gestation). At the third and last visit (8-12 week postpartum), the women will also report
infant birth weight and complications during delivery. The women are asked to bring health
the journal from the hospital and the Infant Health Card
All subjects will complete two sub maximal step treadmill tests. One test immediately after
randomization and the second test at week 36-38 of gestation. The main sub maximal
functional outcome is oxygen uptake and lactate measurements. After adjustments to the
treadmill, nose clip and mouthpiece, all participants start walking on an initial speed of
4.5 km/h. The inclination will elevate each fourth minutes with exactly 4%. Blood pressure,
heart rate and rating of perceived exertion (6-20 scale) (Borg, 1970) are measured during
the last two minutes of every step after steady state is reached based on stable oxygen
uptake measurements. Capillary blood sample for measuring blood lactate is assessed in the
30 second pause after each step. The test is determined after 12-20 minutes when the
subjects blood lactate concentration rise about 1.5 mMol∙L-1 above resting level or perceive
physical exertion between 15-17 (Borg scale) and/or a heart rate < 85% of expected maximal
heart rate. The same exercise physiologist will perform both tests.
All participants gave written consent to participate, and the procedures to be followed are
in accordance with the ethical standards of the responsible regional committee on human
experimentation and adhered to the World Medical Association Declaration of Helsinki. The
project was received and approved by The Committee for Medical Research Ethics, Southern
Norway, Oslo, Norway, on 20 February 2006 (reference number S-05208). Additionally, the
Norwegian Social Sciences Data Services (NNT) provided licence to store and register
individual health information (reference number 17804/2/KH). All data will be stored and
locked in a fireproof cabinet and are in accordance with requisitions from NNT. The
inclusion of women to the trial started in Sept 2007 and will continue till 100 participants
are randomly allocated to the exercise and control groups. All follow-up procedures are
expected to finish within Mars 2009. There is no financial compensation to the participants.
Randomization procedure The randomization procedure will take place after determination of
eligibility, completed baseline examination and measurement of primary outcome variables.
Based on a statistical randomization computer program, an independent person is assigning
the participants to the two groups. The participants will be informed not to reveal any
information about which group they are assigned for to the principal investigator (LH). The
principal investigator is not involved in the training of the women and is blinded to group
allocation while making the outcome measures and plotting all data. It has not been
considered ethically incorrect to use a control group not receiving treatment in present
study.
Exercise program The exercise program consists of supervised exercise for 60 minutes,
performed at least 2 times per week, for 12-16 weeks. Since most participants are working
full time, the exercise groups are arranged in the evening. Each session starts with ca 5
minutes warm up, followed by 30 minutes of aerobic activity, including cool down. This is
followed by 15 minutes of strength training of the upper and lower limbs, and special focus
on the deep abdominal stabilization muscles (the transversus abdominus muscle, pelvic floor
and back muscles). The last 5 minutes contains stretching, relaxation and body awareness
exercises. Aerobic exercises include only low impact exercise (no jumping or running). Step
length and body rotations are reduced to a minimum, and crossings of legs and sharp and
sudden changes of position are avoided. The exercise-program follows the ACOG exercise
prescription, and all aerobic activities will be performed at moderate intensity (60-70% of
maximal heart rate), measured by ratings of perceived exertion at 11-14 (somewhat hard) on
the 6-20 Borg's rating scale. The exercise program is choreographed and led by certified
aerobic instructors, and each session includes maximum 25 participants. In addition to
joining the scheduled aerobic classes, all women are motivated to include 30 minutes of
moderate self-imposed physical activity on the rest of the week-days. They will also be
advised to incorporate short bouts of activity into their daily schedules. For example,
participants are encouraged to walk instead of drive short distances and to use stairs
instead of elevators. The participants are asked to keep daily records of their minutes of
physical activity. Compliance with the training protocol is controlled by the instructors
and registrations in the womens personal training diary. Control-participants are neither
encouraged nor discouraged from exercising.
Statistical analysis Analysis will be completed to assess the effects of the intervention on
two primary and five secondary outcomes: Primary outcomes are overall weight gain during
pregnancy and proportion of participants exceeding weight gain above IOM recommendations.
Secondary outcomes are pregnancy complications, relationship between oxygen consumption,
heart rate and blood lactate concentration at submaximal work loads, infant birth weight,
length of labour and complications during delivery.
The principal analysis will be done on an intention to treat basis. Missing values are
carried forward by their baseline values. The primary dependant variables are total weight
gain and the proportion of women who exceed the IOM recommendations. Average total weight
gain is compared between the two groups and the possible difference is tested using
two-sided independent sample t-test. The group differences in the proportion of participants
who gained weight above the IOM guidelines are tested by using two-sided X2-test.
The secondary outcomes; self-report of complications during pregnancy and delivery, as well
as number of high birth weight infants (≥4200 g) (Skjaerven et al., 2000,Orskou et al.,
2003) will be compared between the intervention and control group and tested using X2-test
or Fisher's exact test. The two-sided independent sample t-test is used to test the
difference in submaximal cardiorespiratory capacity, gestation weeks at delivery, infant's
birth weight and duration of labour. In all statistical analysis, level of statistical
significance is set at p<0.05. Professor of biostatistics, Ingar Holme, Norwegian Scholl of
Sport Science, is advising the present study.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Terminated |
NCT02546193 -
Outpatient Foley Catheter Compared to Usual Inpatient Care for Labor Induction
|
N/A |